Phase I study for immuno-hyperthermia against recurrent subcutaneous tumor using cationic magnetoliposome and alternative magnetic field irradiatio
Phase 1
Recruiting
- Conditions
- subcutaneous recurrent tumor (breast cancer, malignant head and neck tumor, malignant soft tissue tumor, malignant oral cavity tumor)
- Registration Number
- JPRN-UMIN000002701
- Lead Sponsor
- agoya University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 9
Inclusion Criteria
Not provided
Exclusion Criteria
The case having intracorporal magnetic substance (cardiac pace maker, dental implant, steel clips, steel bolts) Pregnant woman, nursing woman The case having pleural effusion, ascites, pericardial effusion which requires emergent treatment The case having active infection The case having double cancer with less than 5 year-disease free period The case having psychological, familial, social, geographical factors which hamper compliance with the protocol and appropriate follow-up The case having brain metastases which require emergent treatment for brain hypertension or emergent irradiation The case who is considered to be inappropriate for this trial by the attending doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Dose limiting toxicity and other adverse events
- Secondary Outcome Measures
Name Time Method